A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3 (HPV-003)This is randomized, placebo controlled study to determine safety and efficacy of VGX-3100 DNA Vaccine delivered by Electroporation to adult women with biopsy-proven HPV 16 or 18 associated Cervical intraepithelial neoplasia grade 2/3 or 3. Principal Investigator Dianne M. MillerBody Locations and Systems Sexually Transmitted Diseases, Cervical CancerArea VancouverAge 18-55
QUEST: QUadrivalent Hpv vaccine Evaluation STudyQUEST (Quadrivalent HPV Vaccine Evaluation Study) is a Canada-wide study designed to evaluate whether 2 doses of the HPV vaccine are just as effective as 3 doses at preventing Human Papillomavirus (HPV) infection and cervical cancer. Principal Investigator Simon DobsonBody Locations and Systems Sexually Transmitted Diseases, Cervical CancerArea VancouverAge 12-17
Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer (Confocal)The goal of this proposal is to determine whether a hand-held confocal microscopy probe may perform better than standard methods in detecting cancer or pre-cancerous abnormalities of the cervix. Principal Investigator Marette H. LeeBody Locations and Systems Cervical CancerArea VancouverAge 18 and above
